We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Lateral Flow Assay Detects Leprosy Immune Response

By LabMedica International staff writers
Posted on 22 May 2014
Field-applicable tests detecting asymptomatic Mycobacterium leprae infection or predicting progression to leprosy are urgently required to determine both cellular and humoral immunity.

Leprosy, a curable infectious disease caused by M. More...
leprae that affects the skin and peripheral nerves, is one of the six diseases considered as a major threat in developing countries as continued transmission in endemic areas likely occurs from the large reservoir of individuals who are infected subclinically.

Infectious disease specialists at the Leiden University Medical Center (The Netherlands) with colleagues in Ethiopia recruited for their study human immunodeficiency virus (HIV)-negative, newly diagnosed untreated leprosy patients, and healthy endemic controls from October 2011 until November 2012. Leprosy was diagnosed based on clinical, bacteriological and histological observations and classified by a skin biopsy.

The combined diagnostic value of interferon (IFN)-γ induced protein 10 (IP-10), interleukin-10 (IL-10) and anti-Phenolic Glycolipid-I (PGL-I) antibodies was tested using M. leprae-stimulated blood of leprosy patients and endemic controls (EC). For reduction of the overall test-to-result time, the minimal whole blood assay time required to detect distinctive responses was investigated. To accommodate Lateral Flow Assays (LFAs) for field settings, dry-format LFAs for IP-10 and anti-PGL-I antibodies were developed allowing storage and shipment at ambient temperatures. Additionally, a multiplex LFA-format was applied for simultaneous detection of anti-PGL-I antibodies and IP-10. For improved sensitivity and quantitation, upconverting phosphor (UCP) reporter technology was applied in all LFAs.

After immunochromatography, LF strips are scanned in a Packard FluoroCount microtiter- plate reader (PerkinElmer; Waltham, MA, USA) adapted with an infrared laser. Upon IR excitation at 980 nm, UCP reporter particles emit green light detectable using a 550 nm band pass filter. For strip analysis in Ethiopia, a lightweight portable LF strip reader with UCP capability was used (UCP-Quant, an ESEQuant LFR reader custom adapted with IR diode; (QIAGEN Lake Constance GmbH; Stockach, Germany).

Single and multiplex UCP-LFAs correlated well with enzyme-linked immunosorbent assays (ELISAs) run in parallel. The performance of dry reagent assays and portable, lightweight UCP-LF strip readers indicated excellent field-robustness. Notably, detection of IP-10 levels in stimulated samples allowed a reduction of the whole blood assay time from 24 hours to six hours. Moreover, IP-10/IL-10 ratios in unstimulated plasma differed significantly between patients and endemic controls, indicating the feasibility to identify M. leprae infection in endemic areas.

The authors concluded that dry-format UCP-LFAs are low-tech, robust assays allowing detection of relevant cytokines and antibodies in response to M. leprae in the field. The high levels of IP-10 and the required shorter whole blood assay time, render this cytokine useful to discriminate between leprosy patients and endemic controls. The study was published on May 8, 2014, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Leiden University Medical Center
PerkinElmer 
QIAGEN Lake Constance GmbH



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chlamydia Pneumoniae Test
Chlamydia Pneumoniae (CP) Real Time PCR Kit
New
Mumps Test
ReQuest MUMPS IgM Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Pathology

view channel
Image: A biomarker discovery pipeline has shown promise as a noninvasive method of diagnosing CRC (Photo courtesy of NCI Center for Cancer Research)

Machine Learning Tool Enables Noninvasive Diagnosis and Monitoring of Colorectal Cancer

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States when considering both genders. Colonoscopy remains the gold standard for CRC diagnosis, but it is invasive,... Read more

Technology

view channel
Image: Scanning electron microscopy images showing 3D micro-printed Limacon-shaped whispering-gallery-mode microcavities with different amounts of deformation (Photo courtesy of A. Ping Zhang/PolyU)

Tiny Microlaser Sensors with Supercharged Biosensing Ability to Enable Early Disease Diagnosis

Optical whispering-gallery-mode microlaser sensors function by trapping light within tiny microcavities. When target molecules bind to the cavity, they induce subtle changes in the laser’s frequency, allowing... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.